|
New Products
|
|
TimTec broadens nature-inspired discovery opportunities with NDL collection of 3000 compounds, Natural Derivatives.
NDL-3000 elaborates on structural variety of pure natural compounds and includes synthetic compounds and synthetically modified pure natural compounds: alkaloids, natural phenols, nucleoside analogs, carbohydrates, purines, pyrimidines, flavonoids, steroidal compounds, and natural amino acids. The list is incomplete. NDL-3000 would be “natural” extension of well-known NPL-480, Library of Pure Natural compounds , in design and structural diversity. NDL-3000 Compounds comply with screening purity standards. NDL-3000 is available as a collection of 3000 compounds, individually, and/or in smaller subsets. Custom formatting in vials, 96/384 plates, is always welcomed. Structural data and pricing information is available on request. Contact us now ! Receive a copy of NLD-3000 or any of TimTec compounds collections on a CDRom - please e-mail us your exact postal address.
Related Information Natural Product Reports article
|
Drug Discovery News
-
Alzheimer’s Study Leads To Better Drug For Infections
Research into Alzheimer’s disease seems an unlikely approach to yield a better way to fight urinary tract infections (UTIs), but that’s what scientists at Washington University School of Medicine in St. Louis and elsewhere recently reported.
One element links the disparate areas of research: amyloids, which are fibrous, sticky protein aggregates. [...]
-
University of California, San Francisco, Researcher Receives ASBMB-Merck Award
Bethesda, MD, December 12, 2009 –(PR.com)– James A. Wells, professor and chairman of the department pharmaceutical chemistry at the University of California, San Francisco, and director of UCSF’s small molecule discovery center, has been named the winner of the 2010 American Society for Biochemistry and Molecular Biology-Merck Award for his [...]
-
Techne accelerates sample concentration
The Techne Sample Concentrator provides fast solvent or diluent evaporation without sample loss when used with one of the company’s Dri-Block heaters.
The height-adjustable head of the concentrator delivers a flow of inert gas that removes evaporated solvent from the surface of solutions in tubes or 96-well plates.
Traditional methods of reducing [...]
-
Potent Novel Tool For Combating Autoimmune Diseases And Leukemia
A study carried out by the scientists at the Scripps Research Institute illustrated a novel, highly practical strategy for identifying molecules that avert a particular form of immune cells from launching assaults on their host. These findings have added a potent new-fangled tool to the ongoing investigation for probable treatments [...]
-
Karwar scientist’s theory to ‘weed’ out CO2
KARWAR: While representatives of 192 countries are engaged in climate change debates at Copenhagen, Dr Ullas Naik, a marine scientist at the department of marine biology, at Karnatak University’s PG Centre, here has suggested the unassuming sea weed as a possible cure to the planet’s ills.Calling for the scientific culture [...]
-
Hi-tech microscopes make androgen therapy ‘personal’
HOUSTON — (December 9, 2009) — On rare occasions, an infant is born with outward appearance of a female but the XY chromosomes of a male. If the child has a normal Y chromosome — the chromosome responsible for testicular development — the condition is known as androgen insensitivity syndrome.
Experts estimate [...]
-
2009: The Year That Was For Pfizer
(RTTNews) - True to expectations, Jeffrey Kindler, the CEO of Pfizer Inc. (PFE | Quote | Chart | News | PowerRating), scripted a new playbook for the drug giant in 2009, accelerating the process of transformation by clinching the largest pharmaceutical [...]
-
Model for powerful flu fighters from existing drugs
Computer compatibility tests might help flu-fighting drugs find their groove.
A pandemic of the H1N1 swine flu virus has health officials worried that the virus could develop resistance to drugs such as Tamiflu used to treat infected people. A new computerized screening method could help find new or already existing drugs that [...]
-
Therasis Obtains $12 Million From Tilocor in Series A Round
GA_googleCreateDomIframe(’google_ads_div_Press336′ ,’Press336′);
GA_googleFillSlot(”Press160″);
GA_googleCreateDomIframe(’google_ads_div_Press160′ ,’Press160′);
NEW YORK, NY — 12/08/09 [...]
-
InformexUSA 2010
InformexUSA has become the leading resource for buyers and sellers of high-value chemistry for a broad range of applications. Today’s pharmaceutical innovators, agrochemical product makers, electronic materials producers and other manufacturers that come to Informex find what they need for business success: mainly new ideas that make a difference, and qualified companies with production assets [...]
|
|
|
|
Call toll free 1 800 574 7391
|